https://www.selleckchem.com/pr....oducts/Puromycin-2HC
110, 95% CI 1.144-3.892, P=0.017) correlated with early recurrence. The 5-year overall survival rates for early and late recurrences were not significantly different (P=0.121). In patients with early recurrence after pCRT followed by TME, tumor regression grade and ypN stage positivity were independent predictors of the early recurrence. In patients with early recurrence after pCRT followed by TME, tumor regression grade and ypN stage positivity were independent predictors of the early recurrence. The extent to which distribution
Like
Comment
Share
